The New Jersey yard is planning to build on the success of the 72 with the brand-new Viking 74 making its world debut at FLIBS. The latest model has a new hull design featuring optimized strakes ...

The New Jersey yard is planning to build on the success of the 72 with the brand-new Viking 74 making its world debut at FLIBS. The latest model has a new hull design featuring optimized strakes and ...

VK2809 is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone beta receptor (TRβ) that possesses selectivity for liver tissue, as well as the beta receptor ...

Viking Therapeutics is a clinical-stage biotech that's looking to compete with Lilly in weight loss treatment. Viking recently revealed plans to develop an obesity treatment that could be superior ...

Viking Therapeutics stock is up over 250% YTD, fueled by its potential weight-loss drug, VK2735. Mixed technical signals ahead of Q3 earnings, with long-term bullishness existing with near-term ...

Archaeologists in Sweden were expecting to find an ancient settlement, but they were surprised to discover a Viking Age cemetery with boat-shaped burial outlines. While digging to find an ancient ...

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted ...

The company’s 50 day moving average price is $63.25 and its two-hundred day moving average price is $61.74. Viking Therapeutics (NASDAQ:VKTX – Get Free Report) last issued its quarterly ...

Viking Therapeutics VKTX is set to report third-quarter earnings on Oct. 23, after market close. Since the company lacks a marketed drug in its portfolio, we do not expect it to record revenues ...